Javascript must be enabled to continue!
Modeling Functional Genetic Alteration in Cancer Reveals New Candidate Driver Genes
View through CrossRef
AbstractCompiling the catalogue of genes actively involved in tumorigenesis (known as cancer drivers) is an ongoing endeavor, with profound implications to the understanding of tumorigenesis and treatment of the disease. An abundance of computational methods have been developed to screening the genome for candidate driver genes based on genomic data of somatic mutations in tumors. Most methods rely on detecting genes displaying excessive mutation rates compared to some background model. This approach is susceptible to false discoveries, due to its sensitivity to the assumptions of the background model, such as the need to account for hyper-mutated samples, cancer types and genomic loci. We present a fundamentally different approach. Instead of focusing on the number of mutations, we examine their content, and their expected effects on the functions of genes. We use a machine-learning model to predict functional effect scores of somatic mutations. For each gene, we compare the distribution of observed effect scores with the distribution expected at random, and report genes showing significant bias. By applying our framework on the ~20k protein-coding human genes, we detected 593 genes showing significant bias towards harmful mutations in the context of cancer. In contrast, we found only 6 significant genes biased in the opposite direction. The list of 593 genes, constructed without any prior knowledge of their role in cancer, shows an overwhelming overlap with known cancer driver genes, but also highlights many overlooked genes. These overlooked genes are promising candidates for novel cancer drivers. Our model is generic and is not restricted to the context of cancer. Applying the same framework to data of human-population genetic variation reveals the opposite trend. Unlike cancer, which is dominated by a bias towards harmful mutations, long-term evolution in healthy individuals results a bias towards less harmful mutations. The underlying assumptions of our framework are minimal, making it ideal for analyzing genetic data in search of genes subjected to positive or negative selection. It is fully open sourced and available for installation and use. Our framework presents a substantial development towards the application of state-of-the-art machine-learning algorithms in genetic studies.
Title: Modeling Functional Genetic Alteration in Cancer Reveals New Candidate Driver Genes
Description:
AbstractCompiling the catalogue of genes actively involved in tumorigenesis (known as cancer drivers) is an ongoing endeavor, with profound implications to the understanding of tumorigenesis and treatment of the disease.
An abundance of computational methods have been developed to screening the genome for candidate driver genes based on genomic data of somatic mutations in tumors.
Most methods rely on detecting genes displaying excessive mutation rates compared to some background model.
This approach is susceptible to false discoveries, due to its sensitivity to the assumptions of the background model, such as the need to account for hyper-mutated samples, cancer types and genomic loci.
We present a fundamentally different approach.
Instead of focusing on the number of mutations, we examine their content, and their expected effects on the functions of genes.
We use a machine-learning model to predict functional effect scores of somatic mutations.
For each gene, we compare the distribution of observed effect scores with the distribution expected at random, and report genes showing significant bias.
By applying our framework on the ~20k protein-coding human genes, we detected 593 genes showing significant bias towards harmful mutations in the context of cancer.
In contrast, we found only 6 significant genes biased in the opposite direction.
The list of 593 genes, constructed without any prior knowledge of their role in cancer, shows an overwhelming overlap with known cancer driver genes, but also highlights many overlooked genes.
These overlooked genes are promising candidates for novel cancer drivers.
Our model is generic and is not restricted to the context of cancer.
Applying the same framework to data of human-population genetic variation reveals the opposite trend.
Unlike cancer, which is dominated by a bias towards harmful mutations, long-term evolution in healthy individuals results a bias towards less harmful mutations.
The underlying assumptions of our framework are minimal, making it ideal for analyzing genetic data in search of genes subjected to positive or negative selection.
It is fully open sourced and available for installation and use.
Our framework presents a substantial development towards the application of state-of-the-art machine-learning algorithms in genetic studies.
Related Results
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
BRDriver: Breast Cancer Driver Gene Predictor
BRDriver: Breast Cancer Driver Gene Predictor
AbstractThe breast cancer mortality rate is high in developing countries as the early detection of cancer is deficient in patients. The identification of the genes that drive cance...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract
Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose:
To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
Mutational Landscape of Cancer-Driver Genes Across Human Cancers
Mutational Landscape of Cancer-Driver Genes Across Human Cancers
AbstractThe cancer driver genes are involved in transforming healthy cells into cancerous cells. The molecular aberrations which lead to cancer involve gain and loss of function mu...
Abstract 1510: Subtype-specific cancer driver gene detection improves sensitivity to detect drivers
Abstract 1510: Subtype-specific cancer driver gene detection improves sensitivity to detect drivers
Abstract
Identifying cancer driver mutations is a crucial step toward understanding the underlying mechanisms of oncogenesis. However, driver gene detection is compl...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Abstract 1530: Identification of vulnerabilities in lung cancer via pooled short hairpin RNA screening
Abstract 1530: Identification of vulnerabilities in lung cancer via pooled short hairpin RNA screening
Abstract
A major goal of cancer research is to identify tumor-specific vulnerabilities by which cancer cells can be selectively killed. The clinical success of targe...

